Several strategies can be employed to streamline regulatory processes:
Adaptive Licensing: Implementing adaptive licensing can allow for earlier approval of treatments based on preliminary data, with continued monitoring and data collection post-approval. Collaboration: Increasing collaboration between regulatory bodies, pharmaceutical companies, and research institutions can help expedite the approval process by sharing data and resources. Harmonization: Harmonizing regulatory standards across different countries can reduce duplication and simplify the global approval process. Use of Technology: Leveraging advanced technologies such as artificial intelligence and machine learning can help analyze trial data more quickly and accurately.
